Tim-Lukas Schubert

The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction.

U. Deuschle, M. Trauner, P. Schwabl, 2017, Journal of hepatology.

Splenectomy ameliorates portal pressure and anemia in animal models of cirrhotic and non-cirrhotic portal hypertension.

B. Hofer, M. Trauner, P. Schwabl, 2022, Advances in medical sciences.

The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction.

U. Deuschle, M. Trauner, P. Schwabl, 2017, Journal of hepatology.